TCL Archive ODAC Recommends Approval Of Paxen; Will IVAX Break Into $1 Billion Market September 26, 1997
TCL Archive Abraxane Improves Progression-Free Survival Compared to Decarbazine In Stage IV Disease November 30, 2012
TCL Archive Benno Schmidt, 86, Cancer Act Advocate, Chairman Of MSKCC boards, Cancer Panel October 29, 1999